vs

Side-by-side financial comparison of Clorox (CLX) and Sunrun Inc. (RUN). Click either name above to swap in a different company.

Clorox is the larger business by last-quarter revenue ($1.7B vs $1.2B, roughly 1.4× Sunrun Inc.). Clorox runs the higher net margin — 9.4% vs 8.9%, a 0.4% gap on every dollar of revenue. On growth, Sunrun Inc. posted the faster year-over-year revenue change (123.5% vs 0.3%). Over the past eight quarters, Sunrun Inc.'s revenue compounded faster (59.0% CAGR vs -8.3%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

Sunrun Inc. is an American provider of photovoltaic systems and battery energy storage products, primarily for residential customers. The company was established in 2007 and is headquartered in San Francisco, California.

CLX vs RUN — Head-to-Head

Bigger by revenue
CLX
CLX
1.4× larger
CLX
$1.7B
$1.2B
RUN
Growing faster (revenue YoY)
RUN
RUN
+123.2% gap
RUN
123.5%
0.3%
CLX
Higher net margin
CLX
CLX
0.4% more per $
CLX
9.4%
8.9%
RUN
Faster 2-yr revenue CAGR
RUN
RUN
Annualised
RUN
59.0%
-8.3%
CLX

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
CLX
CLX
RUN
RUN
Revenue
$1.7B
$1.2B
Net Profit
$157.0M
$103.6M
Gross Margin
43.2%
Operating Margin
8.4%
Net Margin
9.4%
8.9%
Revenue YoY
0.3%
123.5%
Net Profit YoY
-15.6%
103.7%
EPS (diluted)
$1.29
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
RUN
RUN
Q4 25
$1.7B
$1.2B
Q3 25
$724.6M
Q2 25
$2.0B
$569.3M
Q1 25
$1.7B
$504.3M
Q4 24
$1.7B
$518.5M
Q3 24
$1.8B
$537.2M
Q2 24
$1.9B
$523.9M
Q1 24
$1.8B
$458.2M
Net Profit
CLX
CLX
RUN
RUN
Q4 25
$157.0M
$103.6M
Q3 25
$16.6M
Q2 25
$332.0M
$279.8M
Q1 25
$186.0M
$50.0M
Q4 24
$193.0M
$-2.8B
Q3 24
$99.0M
$-83.8M
Q2 24
$216.0M
$139.1M
Q1 24
$-51.0M
$-87.8M
Gross Margin
CLX
CLX
RUN
RUN
Q4 25
43.2%
Q3 25
Q2 25
46.5%
Q1 25
44.6%
Q4 24
43.8%
Q3 24
45.8%
Q2 24
46.5%
Q1 24
42.2%
Operating Margin
CLX
CLX
RUN
RUN
Q4 25
8.4%
Q3 25
0.5%
Q2 25
20.6%
-19.7%
Q1 25
15.2%
-22.8%
Q4 24
14.1%
-628.0%
Q3 24
10.0%
-23.8%
Q2 24
14.5%
-24.4%
Q1 24
-2.3%
-40.0%
Net Margin
CLX
CLX
RUN
RUN
Q4 25
9.4%
8.9%
Q3 25
2.3%
Q2 25
16.7%
49.1%
Q1 25
11.2%
9.9%
Q4 24
11.4%
-542.7%
Q3 24
5.6%
-15.6%
Q2 24
11.4%
26.5%
Q1 24
-2.8%
-19.2%
EPS (diluted)
CLX
CLX
RUN
RUN
Q4 25
$1.29
$0.38
Q3 25
$0.06
Q2 25
$2.68
$1.07
Q1 25
$1.50
$0.20
Q4 24
$1.54
$-12.59
Q3 24
$0.80
$-0.37
Q2 24
$1.74
$0.55
Q1 24
$-0.41
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
RUN
RUN
Cash + ST InvestmentsLiquidity on hand
$227.0M
Total DebtLower is stronger
$14.7B
Stockholders' EquityBook value
$-125.0M
$3.1B
Total Assets
$5.6B
$22.6B
Debt / EquityLower = less leverage
4.69×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
RUN
RUN
Q4 25
$227.0M
Q3 25
Q2 25
$167.0M
Q1 25
$226.0M
Q4 24
$290.0M
Q3 24
$278.0M
Q2 24
$202.0M
Q1 24
$219.0M
Total Debt
CLX
CLX
RUN
RUN
Q4 25
$14.7B
Q3 25
$14.6B
Q2 25
$2.5B
$14.0B
Q1 25
$13.6B
Q4 24
$12.9B
Q3 24
$12.5B
Q2 24
$2.5B
$12.0B
Q1 24
$11.1B
Stockholders' Equity
CLX
CLX
RUN
RUN
Q4 25
$-125.0M
$3.1B
Q3 25
$3.0B
Q2 25
$321.0M
$2.9B
Q1 25
$27.0M
$2.6B
Q4 24
$-41.0M
$2.6B
Q3 24
$60.0M
$5.3B
Q2 24
$328.0M
$5.4B
Q1 24
$91.0M
$5.2B
Total Assets
CLX
CLX
RUN
RUN
Q4 25
$5.6B
$22.6B
Q3 25
$22.2B
Q2 25
$5.6B
$21.2B
Q1 25
$5.5B
$20.4B
Q4 24
$5.6B
$19.9B
Q3 24
$5.5B
$22.1B
Q2 24
$5.8B
$21.4B
Q1 24
$5.8B
$20.8B
Debt / Equity
CLX
CLX
RUN
RUN
Q4 25
4.69×
Q3 25
4.90×
Q2 25
7.74×
4.80×
Q1 25
5.19×
Q4 24
5.05×
Q3 24
2.36×
Q2 24
7.56×
2.23×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLX
CLX
RUN
RUN
Operating Cash FlowLast quarter
$96.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.94×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLX
CLX
RUN
RUN
Q4 25
$96.9M
Q3 25
$-121.5M
Q2 25
$294.0M
$-292.7M
Q1 25
$286.0M
$-104.2M
Q4 24
$180.0M
$-258.4M
Q3 24
$221.0M
$-156.2M
Q2 24
$340.0M
$-208.5M
Q1 24
$182.0M
$-143.1M
Free Cash Flow
CLX
CLX
RUN
RUN
Q4 25
Q3 25
Q2 25
$219.0M
Q1 25
$233.0M
Q4 24
$127.0M
Q3 24
$182.0M
$-156.4M
Q2 24
$259.0M
Q1 24
$127.0M
FCF Margin
CLX
CLX
RUN
RUN
Q4 25
Q3 25
Q2 25
11.0%
Q1 25
14.0%
Q4 24
7.5%
Q3 24
10.3%
-29.1%
Q2 24
13.6%
Q1 24
7.0%
Capex Intensity
CLX
CLX
RUN
RUN
Q4 25
Q3 25
Q2 25
3.8%
Q1 25
3.2%
Q4 24
3.1%
Q3 24
2.2%
0.0%
Q2 24
4.3%
Q1 24
3.0%
Cash Conversion
CLX
CLX
RUN
RUN
Q4 25
0.94×
Q3 25
-7.33×
Q2 25
0.89×
-1.05×
Q1 25
1.54×
-2.08×
Q4 24
0.93×
Q3 24
2.23×
Q2 24
1.57×
-1.50×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLX
CLX

Health And Wellness$643.0M38%
Household$419.0M25%
Lifestyle$321.0M19%
Other$290.0M17%

RUN
RUN

Products$692.3M60%
Customer Agreements$435.2M38%
Manufactured Product Other$56.7M5%
Incentives$31.3M3%

Related Comparisons